To compare disease-specific quality of life (QOL) among patients with sporadic vestibular schwannoma (VS) by tumor management strategy using the recently developed and validated Mayo Clinic VSQOL Index relative to established minimal important difference (MID) thresholds.
Audiologists counseling vestibular schwannoma patients can reference this data to set realistic quality-of-life expectations across management strategies, but the cross-sectional design limits causal conclusions.
Understanding how different vestibular schwannoma management strategies compare on disease-specific quality of life helps audiologists and multidisciplinary teams give patients more informed, evidence-based counseling.
- 01Cross-sectional national study used the Mayo Clinic VSQOL Index for disease-specific QoL measurement.
- 02Three management strategies compared: observation, stereotactic radiation, and surgical resection.
- 03Cross-sectional design means causality between treatment choice and QoL cannot be established.
- 04Disease-specific QoL tools capture hearing, balance, and facial nerve concerns more precisely than generic instruments.
- 05Results can inform shared decision-making conversations between clinicians and patients.
Quality of life differs significantly across vestibular schwannoma management strategies (observation, radiation, surgery) as measured by the Mayo Clinic VSQOL Index.
studypartially supported- PMID
- 42150888
- DOI
- 10.1097/MAO.0000000000004945.
- Journal
- Otology & Neurotology
- Publication type
- research_article
- Evidence level
- 3
- Population
- Adults with sporadic vestibular schwannoma across multiple tumor management strategies
- Intervention
- Tumor management strategy (observation, stereotactic radiation, or surgical resection)
- Comparator
- Observation (watchful waiting)
Primary outcomes
Disease-specific quality of life as measured by the Mayo Clinic VSQOL Index